## **Core Concept**
The core concept being tested here relates to the management of ischemic stroke, specifically the time window within which intravenous (IV) thrombolysis is effective. Ischemic stroke occurs due to an occlusion of a cerebral artery, leading to reduced blood flow to a part of the brain. IV thrombolysis involves administering a medication to dissolve the clot.

## **Why the Correct Answer is Right**
The correct answer, , indicates that IV thrombolysis is of no use in ischemic stroke beyond 4.5 hours. The most widely accepted time window for IV thrombolysis in ischemic stroke is within 4.5 hours of symptom onset. This is because the benefit of thrombolysis decreases significantly and the risk of complications, such as intracranial hemorrhage, increases beyond this time frame. The **alteplase** (tPA) trial and subsequent studies have established that patients treated within 4.5 hours have better outcomes compared to those treated later.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is incorrect because some patients may still benefit from thrombolysis within this timeframe, but it's not the correct upper limit.
- **Option B:** is incorrect because while there might be some benefit in selected cases beyond 6 hours, it's not the standard time limit for IV thrombolysis.
- **Option D:** is incorrect because 12 hours is far beyond the established time window for routine IV thrombolysis in ischemic stroke.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that the time window for IV thrombolysis can be extended to 4.5 hours, but it requires careful patient selection based on specific criteria, including the time of symptom onset, the absence of certain radiographic and clinical contraindications, and the potential to significantly improve outcomes. **Door-to-needle time** (the time from hospital arrival to administration of thrombolytic therapy) should ideally be within 60 minutes.

## **Correct Answer:** . 4.5 hours